Counterfeit risk focus PSI is a focused nonprofit defense body dedicated to protecting public health from pharmaceutical counterfeiting, presenting a clear opportunity to offer advanced security, monitoring, and threat intelligence solutions to its member manufacturers.

Industry collaboration Active with multiple partners including IPR Center, BrandShield, SafetyDetectives, and IPOPHL, PSI demonstrates a strong network effect; sales opportunities exist in providing collaborative platforms, joint threat intelligence, and shared monitoring services for members.

Public reporting Recent launches like the Pharma Fraud report indicate a demand for transparency and data dissemination; potential upsell of customizable analytics dashboards, reporting tools, and subscription-based alerts for members.

Global footprint With international manufacturers and partners, there is a need for scalable security solutions across regions; opportunities include cloud-based investigative workflows, multilingual support, and global threat intel feeds.

Growth potential Revenue range and nonprofit structure suggest high willingness to invest in cost-effective, impact-driven security services; approach with value-based pricing, nonprofit partnerships, and bundled solutions tailored to pharmaceutical security needs.